BIOMARIN PHARMACEUTICAL INC: capex
| Value | {"amount": 66716000, "concept": "us-gaap:PaymentsToAcquirePropertyPlantAndEquipment", "currency": "USD"} |
|---|---|
| Period | 2020-01-01 – 2020-06-30 |
| Status | current |
| Entity | BIOMARIN PHARMACEUTICAL INC |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T10:17:13.171852+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/cd811034-3b9e-4f29-bcb9-3a1f3d60a2d0
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001048477-20-000023Retrieved: 2026-08-19T10:17:13.171852+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001048477/capex/2020-06-30 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/cd811034-3b9e-4f29-bcb9-3a1f3d60a2d0
History
- no predecessors — first report